Lactate dehydrogenase versus haemoglobin: which one is the better marker in paroxysmal nocturnal haemoglobinuria?

被引：9

作者：

Brodsky, Robert A. ^{[1
]}

Lee, Jong Wook ^{[2
]}

Nishimura, Jun-ichi ^{[3
]}

Szer, Jeff ^{[4
]}

机构：

[1] Johns Hopkins Med, Div Hematol, Baltimore, MD 21205 USA

[2] Seoul St Marys Hosp, Cathol Univ Korea, Coll Med, Seoul, South Korea

[3] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan

[4] Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2022年 / 196卷 / 02期

关键词：

COMPLEMENT INHIBITOR ECULIZUMAB; THROMBOSIS;

D O I：

10.1111/bjh.17860

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：264 / 265

页数：2

共 20 条

[1] Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria [J].

Brodsky, Robert A. ;

Young, Neal S. ;

Antonioli, Elisabetta ;

Risitano, Antonio M. ;

Schrezenmeier, Hubert ;

Schubert, Jorg ;

Gaya, Anna ;

Coyle, Luke ;

De Castro, Carlos ;

Fu, Chieh-Lin ;

Maciejewski, Jaroslaw P. ;

Bessler, Monica ;

Kroon, Henk-Andre ;

Rother, Russell P. ;

Hillmen, Peter .

BLOOD, 2008, 111 (04) :1840-1847

[2] How I treat paroxysmal nocturnal hemoglobinuria [J].

Brodsky, Robert A. .

BLOOD, 2021, 137 (10) :1304-1309

[3]

DeZern Amy E, 2018, Biol Blood Marrow Transplant, V24, pe26, DOI 10.1016/j.bbmt.2018.07.032

[4] Significant hemolysis is not required for thrombosis in paroxysmal nocturnal hemoglobinuria [J].

Griffin, Morag ;

Hillmen, Peter ;

Munir, Talha ;

Richards, Stephen ;

Arnold, Louise ;

Riley, Kathryn ;

Hill, Anita .

HAEMATOLOGICA, 2019, 104 (03) :E94-E96

[5] Concurrent treatment of aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience [J].

Griffin, Morag ;

Kulasekararaj, Austin ;

Gandhi, Sheyans ;

Munir, Talha ;

Richards, Stephen ;

Arnold, Louise ;

Benson-Quarm, Nana ;

Copeland, Nicola ;

Duggins, Isabel ;

Riley, Kathryn ;

Hillmen, Peter ;

Marsh, Judith ;

Hill, Anita .

HAEMATOLOGICA, 2018, 103 (08) :E345-E347

[6] Paroxysmal nocturnal haemoglobinuria [J].

Hill, Anita ;

DeZern, Amy E. ;

Kinoshita, Taroh ;

Brodsky, Robert A. .

NATURE REVIEWS DISEASE PRIMERS, 2017, 3

[7] Thrombosis in paroxysmal nocturnal hemoglobinuria [J].

Hill, Anita ;

Kelly, Richard J. ;

Hillmen, Peter .

BLOOD, 2013, 121 (25) :4985-4996

[8] Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria [J].

Hill, Anita ;

Rother, Russell P. ;

Wang, Xunde ;

Morris, Sidney M., Jr. ;

Quinn-Senger, Kerry ;

Kelly, Richard ;

Richards, Stephen J. ;

Bessler, Monica ;

Bell, Leonard ;

Hillmen, Peter ;

Gladwin, Mark T. .

BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (03) :414-425

[9] NATURAL-HISTORY OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA [J].

HILLMEN, P ;

LEWIS, SM ;

BESSLER, M ;

LUZZATTO, L ;

DACIE, JV .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (19) :1253-1258

[10] Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria [J].

Hillmen, Peter ;

Muus, Petra ;

Duhrsen, Ulrich ;

Risitano, Antonio M. ;

Schubert, Jorg ;

Luzzatto, Lucio ;

Schrezenmeier, Hubert ;

Szer, Jeffrey ;

Brodsky, Robert A. ;

Hill, Anita ;

Socie, Gerard ;

Bessler, Monica ;

Rollins, Scott A. ;

Bell, Leonard ;

Rother, Russell P. ;

Young, Neal S. .

BLOOD, 2007, 110 (12) :4123-4128

← 1 2 →